Royal College of Surgeons Ireland:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Royal College of Surgeons Ireland - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9334
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Royal College of Surgeons Ireland (RCSI) is an educational institution that offers medical education and training in healthcare professions at undergraduate and postgraduate levels. The institute provides undergraduate courses in nursing, postgraduate research, leadership courses, and surgical affairs. It operates schools and department that offers services in the areas of medicine, pharmacy, physiotherapy, academic and regulatory affairs, sports and exercise medicine, dentistry, radiology, and others. RCSI provides research in the areas of bioengineering, cancer, cardiovascular, nursing, infection, immunity and inflammation, medicine, neuroscience, gynecology and obstetrics, and others. The institute has operations throughout Ireland. RCSI is headquartered in Dublin, Ireland.

Royal College of Surgeons Ireland – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cynata Therapeutics Enters into Agreement with Royal College of Surgeons 10
Inflection Biosciences Enters into Agreement with Royal College of Surgeons 11
Almac Discovery and Royal College of Surgeons in Ireland Enter into Research Agreement 12
Onxeo Enters into Research Agreement with Royal College of Surgeons in Ireland 13
Royal College of Surgeons Ireland – Key Competitors 14
Royal College of Surgeons Ireland – Key Employees 15
Royal College of Surgeons Ireland – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Oct 10, 2018: Scientists identify chromosomal instability as a novel predictive biomarker for cancer drug Avastin 17
Feb 20, 2017: RCSI research into bowel cancer drugs to have impact on tailored patient treatments 19
Product News 20
Dec 14, 2017: Novel Clinical Study Collaboration Announced Designed to Improve Clinical Care for Hemophilia Patients Through Innovative Personalized Treatment 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Key Facts 2
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Royal College of Surgeons Ireland, Deals By Therapy Area, 2012 to YTD 2018 8
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cynata Therapeutics Enters into Agreement with Royal College of Surgeons 10
Inflection Biosciences Enters into Agreement with Royal College of Surgeons 11
Almac Discovery and Royal College of Surgeons in Ireland Enter into Research Agreement 12
Onxeo Enters into Research Agreement with Royal College of Surgeons in Ireland 13
Royal College of Surgeons Ireland, Key Competitors 14
Royal College of Surgeons Ireland, Key Employees 15

List of Figures
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Royal College of Surgeons Ireland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Royal College of Surgeons Ireland:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Valecha Engineering Ltd:企業の戦略・SWOT・財務情報
    Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • BP Plc (BP.)-石油・ガス分野:企業M&A・提携分析
    Summary BP p.l.c. (BP) is an integrated oil and gas company. It provides fuel, energy, lubricants and petrochemicals to its customers. Its upstream activities include oil and natural gas exploration, field development and production; and midstream operations include transportation, and marketing and …
  • Housing Development Finance Corporation Limited:戦略・SWOT・企業財務分析
    Housing Development Finance Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Housing Development Finance Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Aeon Delight Co Ltd:企業の戦略・SWOT・財務情報
    Aeon Delight Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Aeon Delight Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tulip Star Hotels Limited:企業の戦略・SWOT・財務分析
    Tulip Star Hotels Limited - Strategy, SWOT and Corporate Finance Report Summary Tulip Star Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Renk AG (ZAR):企業の財務・戦略的SWOT分析
    Renk AG (ZAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Petron Corp (PCOR):企業の財務・戦略的SWOT分析
    Petron Corp (PCOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cook Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cook Medical Inc (Cook Medical), that designs, develops and markets medical devices, biological materials and cellular therapies for healthcare market. The company offers products in the fields of critical care medicine, endoscopy, interventional radiology, urology, aortic intervention, lead …
  • Feldan Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Feldan Bio Inc (Feldan) is a biotechnology company. It discovers, develops, manufactures and markets research therapeutic and industrial protein products. The company offers cell therapy products, genome editing products and research products. Its genome editing product includes recombinant …
  • Juntendo University:製薬・医療:M&Aディール及び事業提携情報
    Summary Juntendo University (Juntendo) is a healthcare service provider that offers medical education and research programs and services. The university offers services such as medical education, practices and healthcare services including nursing, consultation, emergency room services, and others. …
  • Cal-Maine Foods Inc (CALM):企業の財務・戦略的SWOT分析
    Cal-Maine Foods Inc (CALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Kimbell Royalty Partners LP (KRP):石油・ガス:M&Aディール及び事業提携情報
    Summary Kimbell Royalty Partners LP (KRP), is an oil and gas company that owns and acquires mineral and royalty interests in oil and natural gas properties throughout the US. The company has interests in the Permian Basin, Eagle Ford, Bakken Shale, San Juan Basin, Mid-Continent, East Texas, Barnett …
  • EyePoint Pharmaceuticals Inc (PSDV):医療機器:M&Aディール及び事業提携情報
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • Kyushu Electric Power Co Inc (9508):電力:M&Aディール及び事業提携情報
    Summary Kyushu Electric Power Co., Inc. (Kyushu Electric) generates electricity, distributes power systems, constructs, maintains, and repairs power generation facilities. It receives stores, vaporizes, delivers, and sells liquefied natural gas (LNG); and purchases, operates, charters and rents LNG …
  • Cembra Money Bank AG:企業の戦略・SWOT・財務情報
    Cembra Money Bank AG - Strategy, SWOT and Corporate Finance Report Summary Cembra Money Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Oaktree Capital Group LLC:企業の戦略・SWOT・財務情報
    Oaktree Capital Group LLC - Strategy, SWOT and Corporate Finance Report Summary Oaktree Capital Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nickel Asia Corporation:企業の戦略・SWOT・財務情報
    Nickel Asia Corporation - Strategy, SWOT and Corporate Finance Report Summary Nickel Asia Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • HiQ International AB (HIQ):企業の財務・戦略的SWOT分析
    Summary HiQ International AB (HiQ International) is a technology and communication company that offers management consultancy services. The company offers communication solutions, development of software, and business-critical IT systems. It provides services in the areas of telecom media, gaming an …
  • Saga plc:企業の戦略・SWOT・財務情報
    Saga plc - Strategy, SWOT and Corporate Finance Report Summary Saga plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • QDVC Q.S.C:企業の戦略的SWOT分析
    QDVC Q.S.C - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆